Top healthcare trends to watch in 2019

Cannabidiol

Cannabidiol (CBD) or CBD oil is no stranger in the integrative healthcare industry. However, with benefits from reducing anxiety to easing chronic pain, it’s safe to say CBD oil is here to stay.

This past June, the U.S. Food and Drug Administration (FDA) approved the first CBD drug to treat rare, severe forms of epilepsy. And with the passing of the 2018 Farm Bill, Congress essentially legalized hemp production with overwhelming support, opening new possibilities and the likelihood that CBD could be legalized or regulated by the FDA for prescription use.

CBD will likely have a big presence on the national political stage, but in patient practice regulation and acceptance are sure to make it easier for practitioners to incorporate in patient protocols.